Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: in vitro studies
Keyword(s):
Endothelins (ETs), 21-amino-acid peptides involved in the pathogenesis of various diseases, bind to ETA and ETB receptors to initiate their effects. Based on the same core structure, we have developed four small-molecule ET receptor antagonists, ABT-627, ABT-546, A-182086 and A-192621, which exhibit difference in selectivity for ETA and ETB receptors. In this report, we compare the potency and selectivity of these four antagonists in inhibiting 125I-labelled ET-1 binding to cloned human ETA and ETB receptors, and in blocking ET-1-induced functional responses (arachidonic acid release and phosphatidylinositol hydrolysis).
1996 ◽
Vol 34
(2)
◽
pp. 167-176
◽
1993 ◽
Vol 22
(Supplement 8)
◽
pp. S168-S170
◽
1992 ◽
Vol 74
(2)
◽
pp. 426-435
◽
Keyword(s):
2001 ◽
Vol 311
(2)
◽
pp. 117-120
◽
Keyword(s):
2006 ◽
Vol 102
(1)
◽
pp. 77-87
◽
1992 ◽
Vol 74
(2)
◽
pp. 426-435
◽
Keyword(s):